Baird: Biogen A Buy On M&A Prospects, Underappreciated Franchises
April 25, 2018 at 12:11 PM EDT
The Street’s becoming increasingly — albeit reluctantly — bullish on Biogen Inc (NASDAQ: BIIB). “While we have ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|